Provided by Tiger Trade Technology Pte. Ltd.

Impact Biomedical, Inc.

0.5748
+0.01011.79%
Post-market: 0.5355-0.0393-6.84%19:59 EDT
Volume:145.83K
Turnover:80.71K
Market Cap:62.08M
PE:-1.51
High:0.5748
Open:0.5534
Low:0.5270
Close:0.5647
52wk High:2.25
52wk Low:0.3621
Shares:108.00M
Float Shares:11.64M
Volume Ratio:0.08
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3800
EPS(LYR):-0.3800
ROE:-104.16%
ROA:-14.16%
PB:4.92
PE(LYR):-1.51

Loading ...

Sep 17, 2024

Major Issues Report

Form 8-K - Current report
Sep 09, 2024

Correspondence

Form CORRESP - Correspondence
Sep 09, 2024

Correspondence

Form CORRESP - Correspondence
Sep 05, 2024

Correspondence

Form CORRESP - Correspondence
Sep 05, 2024

Correspondence

Form CORRESP - Correspondence
Sep 03, 2024

Correspondence

Form CORRESP - Correspondence
Sep 03, 2024

Correspondence

Form CORRESP - Correspondence
Aug 27, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 20, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Correspondence

Form CORRESP - Correspondence
Aug 12, 2024

Correspondence

Form CORRESP - Correspondence
Aug 09, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 08, 2024

Correspondence

Form CORRESP - Correspondence
Aug 08, 2024

Correspondence

Form CORRESP - Correspondence
Jun 11, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 28, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 20, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]